|
2024
|
Invention
|
Formulation of resiniferatoxin.
Disclosed herein are safer formulations of resiniferatoxin (RTX)... |
|
|
Invention
|
Methods for better delivery of active agents to tumors.
The present invention concerns delivery ... |
|
|
Invention
|
Methods for lymphatic delivery of active agents.
The present invention concerns delivery of agen... |
|
2023
|
Invention
|
Protease inhibitors as antivirals. Provided herein, inter alia, are compounds, pharmaceutical com... |
|
|
Invention
|
Application device for a fluid delivery apparatus and method of use. An application device for a ... |
|
2022
|
Invention
|
Device for delivery of rheumatoid arthritis medication.
Disclosed are devices for delivering a r... |
|
|
Invention
|
Dimeric antigen receptors (dar) that bind cd20.
The present disclosure provides dimeric antigen ... |
|
|
Invention
|
Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a... |
|
|
Invention
|
Presurgical perineural administration of resiniferatoxin for reduction of post-operative pain.
D... |
|
|
Invention
|
Fluid delivery apparatus having a controller assembly and method of use.
A method for administer... |
|
|
Invention
|
Dimeric antigen receptors (dars) that bind gd2.
The present disclosure provides transgenic T cel... |
|
|
Invention
|
Microneedle array assembly and fluid delivery apparatus having such an assembly. A microneedle ar... |
|
|
Invention
|
Dimeric antigen receptors (dar) that bind bcma.
The present disclosure provides dimeric antigen ... |
|
|
Invention
|
Administration of resiniferatoxin for treatment of prostate cancer.
Disclosed herein are methods... |
|
|
Invention
|
Device for microliter-scale lymphatic delivery of coronavirus vaccines and methods of use thereof... |
|
2021
|
Invention
|
Transdermal drug delivery apparatus and methods.
A transdermal drug delivery apparatus includes ... |
|
|
Invention
|
Antigen binding proteins that bind pd-1.
There is disclosed compositions and methods relating to... |
|
|
Invention
|
Method for administering a medicament suitable for treating a migraine or cluster headache.
A me... |
|
|
Invention
|
Cd38 antibody drug conjugate.
There is disclosed an antibody drug conjugate (ADC) having an IgG ... |
|
|
Invention
|
Microneedle array assembly, drug delivery device and method for administering liquid across a bro... |
|
|
Invention
|
Nanopatterned medical device with enhanced cellular interaction. A medical device for delivering ... |
|
|
Invention
|
Antibody therapeutics that bind cd137.
There is disclosed compositions and methods relating to o... |
|
|
Invention
|
Cd19-directed chimeric antigen receptor constructs.
Disclosed in the present application are CAR... |
|
|
Invention
|
Antibody therapeutics that bind ctla4.
There is disclosed compositions and methods relating to o... |
|
|
Invention
|
Antigen binding proteins that bind c-met.
There is disclosed compositions and methods relating t... |
|
|
Invention
|
Medical devices for delivery of sirna.
Disclosed are medical devices that incorporate siRNA. In ... |
|
|
Invention
|
Antigen binding proteins that bind bcma.
The present disclosure provides BCMA binding proteins, ... |
|
|
Invention
|
Transdermal delivery of high viscosity bioactive agents.
A device and method for delivery of a b... |
|
|
Invention
|
Variant antibodies that bind ox40. The present disclosure provides variant anti-OX40 antibodies t... |
|
|
Invention
|
Treating pulmonary inflammatory disease by neural ablation.
There is disclosed a method for trea... |
|
|
Invention
|
Implantable devices for delivery of bioactive agents. An implantable delivery device and method f... |
|
|
Invention
|
Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (vegfr2) and me... |
|
|
Invention
|
Oncolytic herpes simplex viruses (hsv) expressing immunomodulatory fusion proteins.
Recombinant ... |
|
|
Invention
|
Anti-pd1 antibodies and uses thereof.
The present disclosure provides PD-1 binding proteins, par... |
|
|
Invention
|
Administration of resiniferatoxin for treatment of bladder pain or bladder cancer.
Disclosed her... |
|
|
Invention
|
Perineural administration of resiniferatoxin for treatment of maladaptive pain. Disclosed herein ... |
|
|
Invention
|
Methods for treating parkinson's disease by administering resiniferatoxin. There is disclosed a m... |
|
|
Invention
|
Antibody drug conjugates having derivatives of amatoxin as the drug.
There is disclosed derivati... |
|
|
Invention
|
Memory dimeric antigen receptors (mdars).
The present disclosure provides transgenic cells that ... |
|
|
Invention
|
Treating pulmonary inflammatory disease associated with covid-19 by administering resiniferatoxin... |
|
|
Invention
|
Innate immunity killer cells targeting psma positive tumor cells.
The present disclosure provide... |
|
|
Invention
|
Activatable antigen binding proteins with universal masking moieties.
The present disclosure pro... |
|
2020
|
Invention
|
Fluid delivery apparatus with microneedles.
Disclosed herein are devices and methods for deliver... |
|
|
Invention
|
Cannabidiol pharmaceutical compositions.
Disclosed herein are aqueous pharmaceutical composition... |
|
|
Invention
|
Engineered variant antibodies that bind cd38.
The present disclosure provides anti-CD38 antigen-... |
|
|
Invention
|
Improved process for integration of dna constructs using rna-guided endonucleases.
There is disc... |
|
|
Invention
|
Improved process for dna integration using rna-guided endonucleases.
There is disclosed an impro... |
|
|
Invention
|
Method for treating osteoarthritis pain by administering resiniferatoxin. Disclosed herein are me... |
|
2019
|
Invention
|
Drug delivery methods targeting the lymphatic system.
Disclosed herein is a method for administe... |
